Decision Diagnostics Corp.
DECN
$0.00
$0.000.00%
| 09/30/2021 | 03/31/2021 | 09/30/2020 | |||
|---|---|---|---|---|---|
| Revenue | -0.42% | -6.27% | -1.48% | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -0.42% | -6.27% | -1.48% | ||
| Cost of Revenue | -5.06% | 14.40% | 5.12% | ||
| Gross Profit | 20.10% | -45.46% | -22.83% | ||
| SG&A Expenses | 36.86% | -30.21% | 7.89% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 16.33% | -16.02% | 6.52% | ||
| Operating Income | -41.49% | 25.23% | -21.30% | ||
| Income Before Tax | 88.28% | -26.51% | -1,399.18% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | 88.28% | -26.51% | -1,399.43% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | 88.28% | -26.51% | -1,399.43% | ||
| EBIT | -41.49% | 25.23% | -21.30% | ||
| EBITDA | -- | -- | -- | ||
| EPS Basic | 89.68% | 41.30% | -675.00% | ||
| Normalized Basic EPS | 89.69% | 48.48% | -646.15% | ||
| EPS Diluted | 89.68% | 41.30% | -675.00% | ||
| Normalized Diluted EPS | 89.69% | 48.48% | -646.15% | ||
| Average Basic Shares Outstanding | 17.42% | 115.35% | 94.95% | ||
| Average Diluted Shares Outstanding | 17.42% | 115.35% | 94.95% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||
